# Feitong (Chengdu) Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/feitong-chengdu-biotechnology-co

- Industry: Pharmaceuticals
- Headquarters: Chengdu, China
- Website: www.soundbiopharma.com
- Total disclosed funding: $4.8M
- Latest round: Angel (Mar 30, 2018)
- Investors on record: 1

## About

Based in Chengdu, China, and established in 2017, Feitong (Chengdu) Biotechnology Co., Ltd is a pharmaceutical company that focuses on providing bio-macromolecular drugs. The founder, CEO, and chairman of the board, Qing Li, graduated from the Chinese University of Hong Kong and has served as a professor of immunology at Sun Yat-sen University. In September 2020, it closed a pre-series A funding.

The company has developed a series of technology platforms including monoclonal antibody screening, antibody humanization and optimization, and so on. The product pipelines have covered the field of cancer and chronic diseases such as autoimmune diseases, cardiovascular diseases, and pain.

## Funding rounds

- Angel, Mar 30, 2018, $4.8M — Apricot Capital

## Investors

- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Angel